Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis. [PDF]
El-Naggar AM +22 more
europepmc +1 more source
HDAC Inhibitors Can Enhance Radiosensitivity of Head and Neck Cancer Cells Through Suppressing DNA Repair. [PDF]
Antrobus J +4 more
europepmc +1 more source
Novel quinazoline-triazole-based <i>N</i>-hydroxybenzamides/<i>N</i>-hydroxypropenamides as HDAC inhibitors: design, synthesis, biological evaluation, and docking studies. [PDF]
Dung NP +10 more
europepmc +1 more source
Reduced EZH1/2 expression in imipridone-treated cells correlates with synergy following combinations with EZH1/2 or HDAC inhibitors in diffuse glioma and other tumors. [PDF]
Zhang Y +8 more
europepmc +1 more source
Treatment with TNFα and lipolysis-stimulated lipoprotein receptor (LSR) antibody in the presence of HDAC inhibitors promotes apoptosis in human salivary duct adenocarcinoma. [PDF]
Nishida S +11 more
europepmc +1 more source
The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos. [PDF]
Shao R, Suzuki T, Suyama M, Tsukada Y.
europepmc +1 more source
Enhancement of innate immunity in gingival epithelial cells by vitamin D and HDAC inhibitors. [PDF]
Figgins EL +8 more
europepmc +1 more source
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers <b>DS-103</b> as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties. [PDF]
Stopper D +15 more
europepmc +1 more source
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap. [PDF]
Zhang H +6 more
europepmc +1 more source
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients. [PDF]
Mozzetta C +3 more
europepmc +1 more source

